Figure 4 | Scientific Reports

Figure 4

From: A novel benzamine lead compound of histone deacetylase inhibitor ZINC24469384 can suppresses HepG2 cells proliferation by upregulating NR1H4

Figure 4

Pathway enrichment of DEGs and DASGs after ZINC24469384 treated in HepG2 cells. (A) IPA canonical pathways of DEGs after ZINC24469384 treated for 4 h, 16 h and 24 h. (B) Pathway analysis of DASGs after ZINC24469384 treated for 4 h, 16 h and 24 h, Incleveldifference >5%, P < 0.05.

Back to article page